Enveric Biosciences Inc vs Shopify Inc. — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Shopify Inc. trades at $126.05 (market cap $160.33B). The key difference: Shopify Inc. is far larger — about 30137.2× Enveric Biosciences Inc's market cap, and Shopify Inc. is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SHOP | |
|---|---|---|
Market Cap | $5.32M | $160.33B |
Sector | Health | Technology |
52-Week High | $17.40 | $179.01 |
52-Week Low | $1.28 | $95.40 |
Enterprise Value | $408.82K | $154.76B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Shopify (SHOP) trades at $125.68, up 0.75% today, with a bullish technical signal from moving averages and support at $124. The company reported strong revenue growth to $11.56 billion in 2025, though net income declined to $1.23 billion. Valuation ratios remain elevated, with a P/E of 121.13, reflecting high growth expectations. Recent news highlights analyst upgrades, including Jefferies raising its price target to $160 on July 13, 2026, citing AI commerce potential.
The outlook is positive, driven by AI integration and global expansion, but risks include slowing growth and high valuation sensitivity. Analyst consensus is bullish with a $150.08 price target, suggesting 19% upside. Investors should weigh robust fundamentals against competitive pressures and macroeconomic headwinds.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →